INS and fatty liver disease: In obese mice, BAM15 decreased hepatic steatosis, reduced proinflammatory lipid intermediates, improved insulin sensitivity (confirmed via hyperinsulinemic-euglycemic clamps), and preserved lean mass and core body temperature [66,68].